NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Stability of phosphoprotein as a biological marker of tumor signaling.

Author(s): Baker AF, Dragovich T, Ihle NT, Williams R, Fenoglio-Preiser C, Powis G

Publication: Clin Cancer Res, 2005, Vol. 11, Page 4338-40

PubMed ID: 15958615 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of cold ischemia time on the stability of phospho-Ser473-Akt (p-Akt) in surgically resected specimens and biopsies.

Conclusion of Paper

p-Akt immunostaining was absent in all surgically resected specimens with unspecified cold ischemia times as well as one with a combined warm and cold ischemia time of 20 min. In biopsies obtained with no cold ischemia time, p-Akt immunostaining was variable leading the authors to conclude that p-Akt should only be evaluated in biopsies that have been rapidly processed and not in postoperative surgical samples.

Studies

  1. Study Purpose

    The purpose of this study was to determine the stability of p-Akt in surgically resected esophagus or gastroesophageal junction specimens with an unspecified cold ischemia time and in small biopsies with no cold ischemia time.

    Summary of Findings:

    Immunostaining of p-Akt was variable in biopsy specimens (9 of 13), and absent in surgically resected specimens (0 of 15). The authors hypothesized that p-Akt was being rapidly dephosphorylated during cold ischemia time in surgically resected specimens, however, cold ischemia times for these specimens were unspecified. A surgically resected colon specimen with a combined warm and cold ischemia time of 20 minutes also had no detectable p-Akt immunostaining. The authors conclude that p-Akt should only be evaluated in biopsies that have been rapidly processed and not in postoperative surgical samples.

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Protein Immunohistochemistry
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Cold ischemia time Unspecified
    0 min
    Less than 20 min
    Biospecimen Acquisition Method of tissue acquisition Biopsy
    Surgical resection

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...